MAGNETIC-RESONANCE-IMAGING OF BRAIN-TUMORS
MAGNETIC-RESONANCE-IMAGING OF BRAIN-TUMORS
复制标题
DOI:
10.1055/s-2008-1041445
复制
发表时间:
1986-03-01
影响因子:
2.7
通讯作者:
SORY, WC
中科院分区:
文献类型:
--
作者:
MARAVILLA, KR;SORY, WC
The ability to detect and diagnose brain tumors underwent a major advance with the introduction of computed tomography (CT) shortly over a decade ago. However, the preoperative, histologic diagnosis of tumors has remained an elusive goal because of the nonspecificity of CT in evaluating brain lesions. Magnetic resonance imaging (MRI) has been hailed as the next major advance in diagnostic imaging of the central nervous system (CNS). The technique offers the promise of improved diagnostic ability through analysis of the magnetic resonance signal emitted by various lesions. However, that hypothesis remains unproved at the present time and considerably more research is needed in MRI technology, especially in the area of spectroscopy, before it can be determined whether, and to what degree, this hope will be realized.Precise tissue diagnosis by MRI is not yet a reality; nonetheless, as a clinical imaging modality, MRI has already proved to be more sensitive than CT for detection of intracranial abnormalities. In CNS neoplasms, MRI is better able to assess the full extent of an infiltrating tumor within the brain. The capability of MRI for obtaining high-resolution, high-contrast images of the brain in axial, coronal, and sagittal orientations allows for three-dimensional assessment of a lesion and a more accurate estimate of its volume and its precise location relative to critical anatomic structures within the brain. Furthermore, as more experience is gained, more precise criteria will be developed for diagnosis of specific lesions. For the foregoing reasons, MRI is able to provide more information about an intracranial abnormality than is possible using CT alone. This, in turn, should enable better treatment planning. Also, since there is no ionizing radiation and no intravenous injection of contrast, MRI should be considered the procedure of choice in postoperative and post-treatment follow-up of patients for evaluating therapeutic response.